Dr Reddys Laboratories (RDY) Share-based Compensation (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Share-based Compensation of $1.04 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 9.7% from $1.15 million a year earlier but up 1.1% from the prior quarter.
Dr Reddys Laboratories (RDY) Share-based Compensation (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Share-based Compensation came in at $4.52 million as of Sep 30, 2026, down 8.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $3 million, down 40.0% from FY2025.
- Annual Share-based Compensation has a five-year compound annual growth rate of -17.8% (FY2021 to FY2026).
- Across earlier fiscal years, Share-based Compensation came in at $5 million in FY2025 (unchanged), $5 million in FY2024 (unchanged), $5 million in FY2023 (-37.5%) and $8 million in FY2022 (unchanged).
- Quarterly Share-based Compensation has ranged from $255,462 in fiscal Q4 2023 to $2.15 million in fiscal Q3 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in 1 of the last four quarters, with an average decline of 8.4%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 357.2% in fiscal Q4 2024, against a decline of 86.4% in fiscal Q4 2023 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 1.04 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.04 Mn |
| Jun 30, 2026 | 1.02 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 255,461.90 |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 2.15 Mn |
| Sep 30, 2021 | 1.93 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | 1.77 Mn |
| Dec 31, 2020 | 2.04 Mn |
Dr Reddys Laboratories Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();